DAIICHI SANKYO CO LTD is a leading Japanese pharmaceutical company that operates in the Large Pharma sector. The company is committed to providing innovative and high-quality pharmaceutical products to improve the health and well-being of people around the world. In recent years, the company has also been focusing on decarbonisation and renewable energy, as part of its efforts to reduce its environmental impact and contribute to a sustainable future.

Corporate Energy and Decarbonisation

DAIICHI SANKYO CO LTD has been working to reduce its carbon footprint and promote decarbonisation across its operations. The company has set a target to reduce its greenhouse gas emissions by 30% by 2030, compared to its 2015 baseline. To achieve this goal, the company has implemented a range of measures to improve energy efficiency and reduce its reliance on fossil fuels.

One of the key initiatives undertaken by DAIICHI SANKYO CO LTD is the installation of renewable energy systems at its facilities. The company has installed solar panels and wind turbines at several of its sites, which generate clean energy to power its operations. In addition, the company has also invested in energy-efficient equipment and technologies, such as LED lighting and advanced HVAC systems, to reduce its energy consumption and carbon emissions.

Corporate PPA and Renewable Energy

DAIICHI SANKYO CO LTD has also entered into corporate power purchase agreements (PPAs) with renewable energy providers, as part of its efforts to increase its use of clean energy. These agreements allow the company to purchase renewable energy directly from wind and solar farms, which helps to support the growth of renewable energy and reduce its reliance on fossil fuels.

In 2020, DAIICHI SANKYO CO LTD signed a PPA with a solar power plant in Japan, which will supply the company with 2,000 megawatt-hours of renewable energy per year. This is equivalent to the annual electricity consumption of around 500 households, and will help the company to reduce its carbon emissions by around 1,000 tonnes per year.

Renewable Energy and Sustainability

DAIICHI SANKYO CO LTD's commitment to renewable energy and sustainability is also reflected in its broader corporate strategy. The company has set a goal to achieve carbon neutrality by 2050, in line with the Paris Agreement on climate change. To achieve this goal, the company is focusing on reducing its carbon emissions, promoting renewable energy, and investing in sustainable technologies and practices.

In addition to its efforts to reduce its environmental impact, DAIICHI SANKYO CO LTD is also committed to promoting social sustainability and contributing to the well-being of communities around the world. The company has implemented a range of initiatives to support access to healthcare and improve health outcomes, particularly in developing countries. These initiatives include partnerships with local healthcare providers, support for medical research and education, and donations of medicines and medical supplies.

Conclusion

DAIICHI SANKYO CO LTD is a leading Japanese pharmaceutical company that operates in the Large Pharma sector. The company is committed to providing innovative and high-quality pharmaceutical products to improve the health and well-being of people around the world. In recent years, the company has also been focusing on decarbonisation and renewable energy, as part of its efforts to reduce its environmental impact and contribute to a sustainable future.

Through its initiatives to promote corporate energy, decarbonisation, corporate PPA, and renewable energy, DAIICHI SANKYO CO LTD is demonstrating its commitment to sustainability and its role as a responsible corporate citizen. As the world faces increasing environmental challenges, companies like DAIICHI SANKYO CO LTD have an important role to play in promoting sustainable practices and contributing to a more sustainable future.